Antibodies directed against a synthetic peptide (src-c) containing the six carboxyl-terminal amino acids of p60rc, the transforming protein of Rous sarcoma virus, recognize p6Oarc. However, when used at sufficiently high concentrations they also react with a number ofconstituents ofuntransformed cells. These reactions can be completely inhibited by src-c peptide. Crossreactivities are to different components in cells from different species and cannot be attributed to p60C §, the ubiquitous cellular homologue ofp6j.C* By indirect immunofluorescence microscopy and immunochemical techniques we have identified three cytoskeletal proteins, myosin, tubulin, and vimentin, as well as an unknown intranuclear antigen, as major targets of anti-src-c antibodies in different untransformed cells. These crossreactivities probably reflect identities or similarities in the amino acid sequence ofthe immunogenic peptide and segments ofthe otherwise unrelated crossreactive proteins. These findings are discussed with respect to the interpretation of crossreactivities that are occasionally observed with anti-peptide sera and with monoclonal antibodies.An attractive possibility for producing antisera against particular proteins is to immunize animals with hapten conjugates made with synthetic oligopeptides corresponding in sequence to selected portions of these proteins (1-8). Because rapid progress in nucleotide sequence analysis allows the prediction of amino acid sequences of an increasing number of proteins, it may be expected that this synthetic approach to the production of monospecific antibodies will find widespread applications in the near future.Recently antibodies have been raised to a synthetic peptide (src-c) corresponding to the carboxyl-terminal hexapeptide sequence of p6src, the transforming protein kinase coded for by the src gene of Rous sarcoma virus (RSV). The amino acid sequence was deduced from the nucleotide sequence (9). These antibodies (referred to as anti-src-c) were then used to investigate the intracellular distribution of p6Osrc (10). By using low concentrations ofaffinity-purified anti-src-c antibodies, specific immunofluorescent labeling ofp6OsfC could be achieved. However, with increasing concentrations of antibody we observed labeling ofconstituents present in untransformed cells or in cells transformed by agents other than RSV. In the present study, these crossreactivities were investigated in detail in order to determine their significance, and in particular whether they might reveal functional or structural relationships between p60srC and the crossreactive normal cell constituents. The results of this study, however, have suggested to us that these crossreactions are fortuitous, but they may occur with some frequency with such anti-peptide antisera. These results also bear on the interpretation of unexpected crossreactivities observed occasionally with monoclonal antibodies.
MATERIALS AND METHODSCell Culture and Immunochemical Reagents. Untransformed and RSV strain B77-transformed normal ...